Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Bluejay Diagnostics, Inc. operates as a medical diagnostics company. The company offers Symphony platform, a technology platform comprising Symphony analyzer that orchestrates whole blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components. It also provides ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, the company develops Symphony IL-6 test for the monitoring of disease progression in critical care settings. Further, it develops cardiac biomarkers, such as hsTNT and NT pro-BNP, as well as other tests using the Symphony platform. The company was incorporated in 2015 and is headquartered in Acton, Massachusetts. more
Time Frame | BJDX | Sector | S&P500 |
---|---|---|---|
1-Week Return | 1.71% | -3.39% | -3.47% |
1-Month Return | 11.8% | -3.25% | -0.29% |
3-Month Return | -44.03% | -11.61% | 4.5% |
6-Month Return | -97.16% | -5.89% | 6.91% |
1-Year Return | -99.64% | 2.65% | 23.79% |
3-Year Return | -99.98% | 0.56% | 28.43% |
5-Year Return | -99.99% | 34.63% | 83.64% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | - | - | 75.00 | 249.04K | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":0.03,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Cost of Revenue | 142.97K | 157.04K | 145.72K | 200.13K | 780.96K | [{"date":"2019-12-31","value":18.31,"profit":true},{"date":"2020-12-31","value":20.11,"profit":true},{"date":"2021-12-31","value":18.66,"profit":true},{"date":"2022-12-31","value":25.63,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Profit | (142.97K) | (157.04K) | (145.72K) | 48.91K | (780.96K) | [{"date":"2019-12-31","value":-292.32,"profit":false},{"date":"2020-12-31","value":-321.07,"profit":false},{"date":"2021-12-31","value":-297.93,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-1596.69,"profit":false}] |
Gross Margin | - | - | (194292.00%) | 19.64% | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-989276.03,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Operating Expenses | 1.63M | 1.20M | 3.16M | 9.37M | 10.31M | [{"date":"2019-12-31","value":15.82,"profit":true},{"date":"2020-12-31","value":11.6,"profit":true},{"date":"2021-12-31","value":30.6,"profit":true},{"date":"2022-12-31","value":90.84,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Income | (1.63M) | (1.20M) | (3.23M) | (9.32M) | (10.31M) | [{"date":"2019-12-31","value":-163141300,"profit":false},{"date":"2020-12-31","value":-119639100,"profit":false},{"date":"2021-12-31","value":-323016300,"profit":false},{"date":"2022-12-31","value":-931777600,"profit":false},{"date":"2023-12-31","value":-1031121600,"profit":false}] |
Total Non-Operating Income/Expense | 863.86K | 11.11K | (625.59K) | (77.09K) | 522.23K | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":1.29,"profit":true},{"date":"2021-12-31","value":-72.42,"profit":false},{"date":"2022-12-31","value":-8.92,"profit":false},{"date":"2023-12-31","value":60.45,"profit":true}] |
Pre-Tax Income | (819.84K) | (1.16M) | (3.49M) | (9.30M) | (9.95M) | [{"date":"2019-12-31","value":-81984200,"profit":false},{"date":"2020-12-31","value":-115828500,"profit":false},{"date":"2021-12-31","value":-348829800,"profit":false},{"date":"2022-12-31","value":-929694800,"profit":false},{"date":"2023-12-31","value":-995388800,"profit":false}] |
Income Taxes | (62.13K) | (32.57K) | 241.39K | (69.06K) | 5.00 | [{"date":"2019-12-31","value":-25.74,"profit":false},{"date":"2020-12-31","value":-13.49,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-28.61,"profit":false},{"date":"2023-12-31","value":"-","profit":true}] |
Income After Taxes | (757.72K) | (1.13M) | (3.73M) | (9.23M) | (9.95M) | [{"date":"2019-12-31","value":-75771600,"profit":false},{"date":"2020-12-31","value":-112571600,"profit":false},{"date":"2021-12-31","value":-372968600,"profit":false},{"date":"2022-12-31","value":-922788900,"profit":false},{"date":"2023-12-31","value":-995389300,"profit":false}] |
Income From Continuous Operations | (819.84K) | (1.16M) | (3.49M) | (9.30M) | (10.04M) | [{"date":"2019-12-31","value":-81984200,"profit":false},{"date":"2020-12-31","value":-115828500,"profit":false},{"date":"2021-12-31","value":-348829800,"profit":false},{"date":"2022-12-31","value":-929694800,"profit":false},{"date":"2023-12-31","value":-1003740000,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (757.72K) | (1.13M) | (3.73M) | (9.23M) | (9.95M) | [{"date":"2019-12-31","value":-75771600,"profit":false},{"date":"2020-12-31","value":-112571600,"profit":false},{"date":"2021-12-31","value":-372968600,"profit":false},{"date":"2022-12-31","value":-922788900,"profit":false},{"date":"2023-12-31","value":-995388800,"profit":false}] |
EPS (Diluted) | (0.02) | (0.14) | (0.39) | (0.47) | (6.81) | [{"date":"2019-12-31","value":-2.45,"profit":false},{"date":"2020-12-31","value":-13.67,"profit":false},{"date":"2021-12-31","value":-39.3,"profit":false},{"date":"2022-12-31","value":-47,"profit":false},{"date":"2023-12-31","value":-681,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
BJDX | |
---|---|
Cash Ratio | 5.49 |
Current Ratio | 6.26 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
BJDX | |
---|---|
ROA (LTM) | -58.51% |
ROE (LTM) | -125.25% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
BJDX | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.14 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.86 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
BJDX | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 54.99 |
P/B | 0.33 |
Price/FCF | NM |
EV/R | 5.67 |
EV/Ebitda | NM |
Bluejay Diagnostics Inc (BJDX) share price today is $3.89
Yes, Indians can buy shares of Bluejay Diagnostics Inc (BJDX) on Vested. To buy Bluejay Diagnostics Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in BJDX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Bluejay Diagnostics Inc (BJDX) via the Vested app. You can start investing in Bluejay Diagnostics Inc (BJDX) with a minimum investment of $1.
You can invest in shares of Bluejay Diagnostics Inc (BJDX) via Vested in three simple steps:
The 52-week high price of Bluejay Diagnostics Inc (BJDX) is $1260. The 52-week low price of Bluejay Diagnostics Inc (BJDX) is $3.03.
The price-to-earnings (P/E) ratio of Bluejay Diagnostics Inc (BJDX) is
The price-to-book (P/B) ratio of Bluejay Diagnostics Inc (BJDX) is 0.33
The dividend yield of Bluejay Diagnostics Inc (BJDX) is 0.00%
The market capitalization of Bluejay Diagnostics Inc (BJDX) is $2.31M
The stock symbol (or ticker) of Bluejay Diagnostics Inc is BJDX